COMMUNIQUÉS West-GlobeNewswire

-
Parallax Health Sciences Announces Licensing Agreement With HealthPointe Solutions
18/07/2019 -
First Patient Enrolled in Phase 1b/2 Trial of Lixte Biotechnology’s LB-100 in Low or Intermediate-1 Risk Myelodysplastic Syndrome
18/07/2019 -
eSolutions Celebrates 20th Anniversary with Rebrand
18/07/2019 -
Nemaura Medical Inc. Appoints Chris Avery as Vice President of Global Business Operations to Support Global Commercial Launch of SugarBEAT®
18/07/2019 -
Alphatec Announces Commercial Launch of ALIF IdentiTi™ Porous Titanium Interbody System Implant
18/07/2019 -
MannKind Repays Maturing Debt Obligation; Buys Back Certain Warrants
18/07/2019 -
SeaSpine Announces Portfolio Expansion of OsteoStrand™ and OsteoStrand™ Plus Demineralized Bone Fibers
18/07/2019 -
MyoKardia Announces HCM Program Updates: Accelerates Timing for Mavacamten Topline Phase 3 Data; Re-acquires U.S. Royalty Rights to HCM Programs from Sanofi
18/07/2019 -
Organovo Announces Release Date for Fiscal First-Quarter 2020 Financial Results
18/07/2019 -
Genocea to Host Quarterly Corporate Update Conference Call & Webcast on July 25th at 8:30 am ET
18/07/2019 -
Executive Women In Bio Selects Candidates for 2019 Boardroom Ready Program
18/07/2019 -
Samumed Announces Publication of Preclinical Data Demonstrating That SM07883 is a Potential Treatment for Alzheimer’s Disease
18/07/2019 -
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data and Artificial Intelligence-Driven Approach to Treating Ovarian Cancer
18/07/2019 -
Chembio Diagnostics and Takeda Pharmaceutical Company Enter Collaboration to Develop Point-of-Care Diagnostic Test
18/07/2019 -
The New Hemp Energy Drink Will Be Offered to Consumers in 700 Additional Stores in Five Provinces
18/07/2019 -
Progressive Care Inc. Garners Coverage in Publicly Traded Podcasts
18/07/2019 -
Adaptimmune Starts the SURPASS Clinical Trial with its first Next-Generation SPEAR T-cells Targeting MAGE‑A4 to Enhance Antitumor Responses
18/07/2019 -
Iovance Biotherapeutics Appoints Friedrich Graf Finckenstein, M.D., as Chief Medical Officer
18/07/2019 -
The Joint Corp. Acquires Four Clinics
18/07/2019
Pages